Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1.
Trsova I, Hrustincova A, Krejcik Z, Kundrat D, Holoubek A, Staflova K, Janstova L, Vanikova S, Szikszai K, Klema J, Rysavy P, Belickova M, Kaisrlikova M, Vesela J, Cermak J, Jonasova A, Dostal J, Fric J, Musil J, Dostalova Merkerova M. Trsova I, et al. Among authors: vesela j. Mol Oncol. 2023 Dec;17(12):2565-2583. doi: 10.1002/1878-0261.13486. Epub 2023 Jul 17. Mol Oncol. 2023. PMID: 37408496 Free PMC article.
TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.
Belickova M, Vesela J, Jonasova A, Pejsova B, Votavova H, Merkerova MD, Zemanova Z, Brezinova J, Mikulenkova D, Lauermannova M, Valka J, Michalova K, Neuwirtova R, Cermak J. Belickova M, et al. Among authors: vesela j. Oncotarget. 2016 Jun 14;7(24):36266-36279. doi: 10.18632/oncotarget.9200. Oncotarget. 2016. PMID: 27167113 Free PMC article.
Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution.
Svobodova K, Lhotska H, Hodanova L, Pavlistova L, Vesela D, Belickova M, Vesela J, Brezinova J, Sarova I, Izakova S, Lizcova L, Siskova M, Jonasova A, Cermak J, Michalova K, Zemanova Z. Svobodova K, et al. Among authors: vesela d, vesela j. Genes Chromosomes Cancer. 2020 Jul;59(7):396-405. doi: 10.1002/gcc.22841. Epub 2020 Mar 25. Genes Chromosomes Cancer. 2020. PMID: 32170980
Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome.
Hrustincova A, Krejcik Z, Kundrat D, Szikszai K, Belickova M, Pecherkova P, Klema J, Vesela J, Hruba M, Cermak J, Hrdinova T, Krijt M, Valka J, Jonasova A, Merkerova MD. Hrustincova A, et al. Among authors: vesela j. Cells. 2020 Mar 26;9(4):794. doi: 10.3390/cells9040794. Cells. 2020. PMID: 32224889 Free PMC article.
LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome.
Szikszai K, Krejcik Z, Klema J, Loudova N, Hrustincova A, Belickova M, Hruba M, Vesela J, Stranecky V, Kundrat D, Pecherkova P, Cermak J, Jonasova A, Dostalova Merkerova M. Szikszai K, et al. Among authors: vesela j. Cancers (Basel). 2020 Sep 23;12(10):2726. doi: 10.3390/cancers12102726. Cancers (Basel). 2020. PMID: 32977510 Free PMC article.
87 results